Valuation: Adocia

Market Cap 5.14Cr 5.76Cr 4.78Cr 4.35Cr 8.18Cr 545.61Cr 8.33Cr 57Cr 22Cr 284.67Cr 22Cr 21Cr 910.94Cr P/E 2026 *
5.75x
P/E 2027 * 3.72x
Enterprise Value 26.54L 29.73L 24.66L 22.43L 42.21L 28Cr 42.97L 2.96Cr 1.16Cr 15Cr 1.12Cr 1.09Cr 47Cr EV / Sales 2026 *
0.17x
EV / Sales 2027 * 2.17x
Free-Float
94.55%
Yield 2026 *
-
Yield 2027 * -
1 day+18.43%
1 week+27.86%
Current month+4.05%
1 month-29.86%
3 months-34.44%
6 months-45.41%
Current year-61.64%
1 week 2.02
Extreme 2.02
2.62
1 month 2.01
Extreme 2.01
3.79
Current year 2.01
Extreme 2.01
7.45
1 year 2.01
Extreme 2.01
10.18
3 years 2.01
Extreme 2.01
12.66
5 years 2.01
Extreme 2.01
16.16
10 years 2.01
Extreme 2.01
61.9
Manager TitleAgeSince
Chief Executive Officer 55 11/05/2023
Director of Finance/CFO - 23/09/2024
Chief Tech/Sci/R&D Officer - 01/12/2014
Director TitleAgeSince
Director/Board Member 55 19/04/2013
Chairman 57 -
Director/Board Member 61 11/05/2023
Date Insider Type Main position Quantity % Market Cap. Importance
27/02/25 Buy

Founder

1,09,170 0.6972%
06/04/24 Buy

Founder

15,576 0.1105%
06/04/24 Buy

Founder

51,921 0.3685%
Change 5-day change 1-year change 3-year change Capi.($)
+18.43%+27.86%-76.20%-67.92% 5.76Cr
+0.21%-4.63%+55.34%+71.32% 6.9TCr
+1.66%+7.51%+8.12%+60.04% 5.31TCr
+3.14%+7.17%+12.48%+44.42% 5.08TCr
+3.45%+4.70%+33.44%+35.96% 4.46TCr
-2.20%+0.61%+281.88%+532.76% 4.06TCr
+6.43%+6.84%+18.32%+109.23% 4.25TCr
+1.28%+1.39%+11.69%+45.10% 3.09TCr
+2.43%-7.48%+35.90%+1.67% 2.54TCr
+1.74%-2.02%-13.55%-12.92% 2.27TCr
Average +3.66%+4.19%+36.74%+81.97% 3.8TCr
Weighted average by Cap. +1.95%+2.34%+51.48%+103.67%

Financials

2026 *2027 *
Net sales 1.55Cr 1.73Cr 1.44Cr 1.31Cr 2.46Cr 163.99Cr 2.5Cr 17Cr 6.75Cr 86Cr 6.5Cr 6.36Cr 273.79Cr 3.76Cr 4.21Cr 3.49Cr 3.18Cr 5.98Cr 398.96Cr 6.09Cr 42Cr 16Cr 208.16Cr 16Cr 15Cr 666.09Cr
Net income 3L 4L 3L 3L 5L 3.52Cr 5L 37.01L 14.48L 1.84Cr 13.94L 13.64L 5.87Cr -4.43Cr -4.97Cr -4.12Cr -3.75Cr -7.05Cr -470.36Cr -7.18Cr -49Cr -19Cr -245.41Cr -19Cr -18Cr -785.31Cr
Net Debt -4.88Cr -5.46Cr -4.53Cr -4.12Cr -7.76Cr -517.45Cr -7.9Cr -54Cr -21Cr -269.98Cr -21Cr -20Cr -863.93Cr 3.02Cr 3.38Cr 2.8Cr 2.55Cr 4.8Cr 320.2Cr 4.89Cr 34Cr 13Cr 167.07Cr 13Cr 12Cr 534.6Cr
Projected Income Statement - Annual - Adocia
Logo Adocia
Adocia is a biotechnology company specializing in the discovery and development of therapeutic solutions in the field of metabolic diseases, primarily diabetes and obesity. The Company has a broad portfolio of drug candidates based on four proprietary technology platforms : BioChaperone® for the stabilization and enhancement of peptide formulations and combinations, AdoXLongTM, a long-acting peptide platform, AdOral®, an oral peptide delivery technology, and AdoShell®, an immunoprotective biomaterial for cell transplantation, with an initial application in pancreatic cells transplantation.
Employees
80
Date Price Change Volume
15/26/15 €2.570 +18.43% 5,03,601
14/26/14 €2.170 +7.43% 1,30,842
13/26/13 €2.020 -3.26% 90,581
12/26/12 €2.088 +1.66% 1,03,879
09/26/09 €2.054 +2.19% 1,67,363
Trader
Investor
-
Global
-
Quality
-
ESG MSCI
-
MarketScreener Ratings - Adocia
Sell
Consensus
Buy
Mean consensus
BUY
Number of Analysts
4
Last Close Price
2.570EUR
Average target price
9.700EUR
Spread / Average Target
+277.43%

Quarterly revenue - Rate of surprise

Rate of surprise - Net sales - Quarterly - Adocia
  1. Stock Market
  2. Stocks
  3. ADOC Stock